REQUEST A DEMO
Total
USD $0.00
Search more companies

Fundacion Neuroncologica del Oriente (Colombia)

Main Activities: General Medical and Surgical Hospitals
Full name: Fundacion Neuroncologica del Oriente Profile Updated: May 13, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Fundacion Neuroncologica del Oriente is an enterprise in Colombia, with the main office in Piedecuesta. It operates in the General Medical and Surgical Hospitals industry. The enterprise was incorporated on September 16, 2020. Fundacion Neuroncologica del Oriente currently employs 29 (2026) people. There was a net sales revenue drop of 11.31% reported in Fundacion Neuroncologica del Oriente’s latest financial highlights for 2025. Its total assets decreased by 7.6% over the same period. In 2025, Fundacion Neuroncologica del Oriente’s net profit margin increased by 4.23%.

Headquarters
Kilometro 7 Autopista Bucaramanga Piedecuesta Cie Consultorios 801 - 802 - 803 - 804 - 805 - 806 - 807 - 808 - 810 - 824
Piedecuesta; Santander;

Contact Details: Purchase the Fundacion Neuroncologica del Oriente report to view the information.

Basic Information
Total Employees:
Purchase the Fundacion Neuroncologica del Oriente report to view the information.
Financial Auditors:
Purchase the Fundacion Neuroncologica del Oriente report to view the information.
Incorporation Date:
September 16, 2020
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Fundacion Neuroncologica del Oriente report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-11.31%
Total Operating Revenue
-11.31%
Net Profit/Loss for the Period
60.79%
Total Assets
-7.6%
Total Equity
69.05%
Net Profit Margin
4.23%
Return on Equity (ROE)
-2.15%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?